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http://dx.doi.org/10.1016/j.jds.2012.1Abstract Background/purpose: The expanded mesh connective tissue graft (e-MCTG) is an
effective method for the treatment of multiple adjacent recession-type defects (MARD).
Platelet-rich fibrin (PRF) is a second-generation platelet concentrate. The aim of the present
study was to assess the effectiveness and the predictability of the PRF membrane (PRF-M) for
the treatment of MARD, and also to compare it with e-MCTG.
Materials and methods: A total of 106 buccal gingival recessions were treated with coronally
advanced flap (CAF)þ (e-MCTG) or with (CAF)þ (PRF-M). Clinical measurements recorded at
baseline and 6 months after surgery included plaque index and gingival index, probing depth,
recession depth, recession width, apicocoronal width of keratinized tissue, and clinical attach-
ment level.
Results: Six months after the surgery, statistically significant gain in root coverage, recession
width, clinical attachment level, and keratinized tissue were assessed in both groups. No sta-
tistically significant difference was found between the two groups for all of these parameters.
Conclusion: The results of this study indicate that the use of PRF allowed the treatment of
MARD with adequate wound healing and highly predictable root coverage. More expanded clin-
ical studies are needed to confirm these findings.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Dentistry, Department of Periodontology, Gazi University, 8, Cadde 84, Sok 06510, Emek, Ankara,
.tr (D. Cetiner).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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Treatment of multiple recession-type defects 37Introduction of cells such as dental pulp cells,
25 human osteoblasts,26
27Gingival recession (GR) is defined as the partial denudation
of the root surface due to the apical migration of the soft
tissue to the cementoeenamel junction (CEJ).1,2 There are
varied etiologic and predisposing factors related to GR,
including trauma from tooth brushing, malposition of teeth,
frenilia, and muscle attachments.3 GR is a typically com-
mon clinical condition4e6 and may result in esthetic prob-
lems, inadequate plaque control, root caries, and dentin
hypersensitivity.4,7
The treatment of multiple adjacent recession-type de-
fects (MARD) with different surgical procedures depends on
many factors, such as defect size, presence or absence of
keratinized tissue adjacent to the defect, and thickness of
the gingiva, which are related to the defect and/or the
patient. Numerous surgical procedures have been described
to achieve root coverage (RC) based on coronally positioned
flaps, pedicle grafts, free gingival grafts; subepithelial
connective tissue grafts (CTG); and guided tissue
regeneration.8e10
MARD presents a further challenge because several re-
cessions must be treated at a single surgical session to
minimize patient discomfort.11 For these reasons, recent
studies have aimed to develop new techniques for RC of
multiple adjacent recessions.
The CTG technique is currently one of the most pre-
dictable and reproducible techniques to achieve RC and a
high degree of esthetics. Although excellent esthetic re-
sults have been reported and RC has ranged from 69% to 97%
in many studies, this technique requires a suitable donor
site. Inherent problems with RC grafting are a limited
quantity of available graft, the need for two surgical sites,
compromised patient esthetics, postoperative discomfort,
and complications.
The quality of healing after RC has been examined in a
few histological studies.12e15 Although the formation of
long junctional epithelium is generally expected after
conventional mucogingival surgery,14,15 a limited amount of
regeneration can be achieved with conventional tech-
niques.12,13 Therefore, various adjunctive agents have been
used to accelerate healing and further enhance clinical
outcomes. These include root conditioners,16 enamel ma-
trix proteins,17 recombinant human growth factors, and
platelet-rich plasma (PRP).18 PRP has become a focus of
current studies because of its potential to accelerate
wound healing.19,20
Platelet-rich fibrin (PRF), which was introduced by
Choukroun et al in 2001, can be considered a second-
generation platelet concentrate. Using PRF requires very
simple techniques because, unlike other platelet concen-
trates, it does not require anticoagulants or bovine
thrombin. Blood is collected in dry glass tubes or glass-
coated plastic tubes and centrifuged immediately, and the
fibrin clot is formed in the middle of the tube.21 Unlike the
other platelet concentrates, PRF was defined as an autolo-
gous leukocyte and PRF biomaterial, because in thismethod,
platelets and leukocytes are collected with high efficiency
such that the growth factors will able to release gradually
during at least 1 week.22e24 It has been shown in different
studies that PRF has a proliferative effect on different typeshuman gingival and periodontal ligament fibroblasts,
dermal prekeratinocytes, and preadipcytes.26,28,29 This ho-
mogeneous fibrin network is considered a healing biomate-
rial and is used to enhance bone regeneration and soft tissue
healing in implant and periodontal plastic surgery pro-
cedures,30 healing of extraction sockets,31 and treatment of
intrabony defects32 and radicular cysts.33
The aims of the present study were to assess the
effectiveness and the predictability of PRF membrane (PRF-
M) with coronally advanced flap [(CAF)þ (PRF-M)] for the
treatment of MARD, and also to compare it with (CAF)þ
expanded mesh connective tissue graft (e-MCTG).Materials and methods
Patient selection
This study is a split-mouth, randomized, controlled clinical
trial designed to compare the outcomes of two surgical
procedures for RC. The study protocol was reviewed and
approved by the Ethical Board of Gazi University (2010/78).
The 20 patients were consecutively referred to the
Department of Periodontology, University of Gazi. The
study was conducted in accordance with the Helsinki
Declaration of 1975, as revised in 2000. Written informed
consent was obtained from all patients after a thorough
explanation of the nature, risks, and benefits of the clinical
investigation and associated procedures. The individuals
who reported between November 2010 and June 2011 were
included in the study.
The patient selection was based on the following
criteria: at least three adjacent maxillary or mandibular
Miller Class I and/or Class II GR defects 2 mm in depth;
systemic health; presence of identifiable CEJ; good plaque
control [full-mouth plaque index (PI) <20%]; vital teeth; no
caries or restoration on the selected teeth; absence of
bleeding on probing at the surgical sites; and probing depth
(PD) of 2 mm. All participants were in good health and
were not aware of any systemic conditions.
Exclusion criteria were as follows: previous surgical
attempt to correct gingival recession; fixed orthodontic or
removable appliance; current smoking or chewing of to-
bacco; endodontically treated sites or root surface resto-
rations on sites; systemic disease; coagulation defect or
current anticoagulation treatment; and pregnancy.
All participants met the aforementioned inclusion
criteria before enrollment in this study.
Twenty patients aged 23e48 [33.7 7.12 (mean SD)]
years complaining of esthetic problems or dentinal hyper-
sensitivity were enrolled in the study. Five female patients
were excluded because they did not comply with the study
protocol. A total of 106 buccal gingival recessions were
treated in 15 individuals (9 men, 6 women). Patients had
recession defects, thus allowing test (CAF)þ (PRF-M) and
control (CAF)þ (e-MCTG) procedures to be undertaken in
the upper and lower arches. Test and control sides were
determined by tossing a coin.
The test group included 54 buccal gingival recessions (21
teeth on maxilla, 33 teeth on mandibula) (Table 1). Test
Table 1 Location and number of recessions in each patient.
Patient
number
Sex (CAF)þ (PRF-M) group (CAF)þ (e-MCTG) group
Number of teeth and location Number of teeth and location
1 Female nZ 5, maxilla, leftþ right side nZ 3, mandibula, left side
2 Female nZ 5, maxilla, leftþ right side nZ 4, mandibula, left side
3 Male nZ 4, maxilla, left side nZ 3, mandibula, right side
4 Male nZ 4, maxilla, right side nZ 4, mandibula, right side
5 Female nZ 3, mandibula, left side nZ 4, maxilla, left side
6 Male nZ 3, mandibula, left side nZ 4, maxilla, left side
7 Male nZ 4, mandibula, right side nZ 4, maxilla, leftþ right side
8 Female nZ 4, mandibula, right side nZ 4, maxilla, left side
9 Male nZ 3, mandibula, left side nZ 3, mandibula, right side
10 Female nZ 3, mandibula, right side nZ 3, mandibula, left side
11 Female nZ 3, mandibula, left side nZ 4, maxilla, leftþ right side
12 Male nZ 3, maxilla, right side nZ 3, mandibula, left side
13 Male nZ 4, mandibula, right side nZ 3, mandibula, left side
14 Male nZ 3, mandibula, left side nZ 3, mandibula, right side
15 Male nZ 3, mandibula, right side nZ 3, mandibula, left side
(CAF)þ (PRF-M)Z treatment with coronally advanced flap and platelet-rich fibrin membrane; (CAF)þ (e-MCTG)Z treatment with
coronally advanced flap and expanded mesh connective tissue graft.
38 A. Uraz et alsides were treated with (CAF)þ (PRF-M). The control group
included 52 buccal gingival recessions (20 teeth on maxilla,
32 teeth on mandibula) (Table 1). Control sides were
treated with (CAF)þ (e-MCTG).
Clinical measurements
The following clinical measurements were recorded to the
nearest millimeter on the midbuccal aspect of each of the
selected sites immediately after the initial therapy and
again 6 months after surgery with the aid of an acrylic stent
to determine the exact measurement site: (1) recession
depth (RD)measured from the CEJ to the gingival margin; (2)
recession width measured across the buccal surface at the
CEJ level (the tangent of lowest of CEJwas used as reference
point); (3) PD measured from gingival margin to the bottom
of the gingival sulcus; (4) clinical attachment level (CAL)
measured from CEJ to the bottom of the gingival sulcus; (5)
apicocoronal width of keratinized tissue (KT) measured from
gingival margin to mucogingival junction: the location of the
mucogingival junction was established using a visual
method; PI34 and gingival index35 (GI) scores were also
documented. All clinical measurements were performed by
the same blinded and calibrated examiner (YS).
The investigator in charge of the clinical assessments was
calibrated for intraexaminer repeatability before the trial
began. Four patients were enrolled for this purpose. Dupli-
cate measurements for clinical records were obtained with
an interval of 24 hours between the first and the second
recording. The intraclass correlation coefficient, used as a
measure of intraexaminer reproducibility, was 0.95.
Presurgical procedures
All participants received initial therapy including oral hy-
giene instructions, scaling, professional tooth cleaning
using a rubber tip with a low-abrasive polishing paste,occlusal adjustment if indicated, and elimination of habits
related to the etiology of recession. The participants were
instructed to use the modified Stillman brushing technique.
One month after the initial therapy, clinical measurements
were recorded, and the participants underwent the surgical
procedure.
Surgical procedures
After baseline recordings, both surgical operations (test
and control) were performed by the same clinicians. The
same clinician (DC¸) always performed the operation,
whereas the other surgeon (AU) assisted in the procedure.
The facial skin all around the oral cavity was scrubbed
with a 7.5% povidineeiodine solution. Local anesthesia was
obtained by regional blocks with 2% lidocaine with
1:100,000 epinephrine. Next, an intrasulcular incision was
made corresponding to the number of adjacent gingival
recession, extending to the line angles of both adjacent
teeth that had no defect. When needed, slightly oblique
releasing incisions were made starting at least 0.5 mm from
the gingival margin of the adjacent teeth and extending to
the alveolar mucosa. A full-thickness flap was elevated 3 to
4 mm apical to the bone dehiscence. This was followed by
split thickness sharp dissection further apically to allow
coronal positioning of the flap as described previously. All
papillae were de-epithelialized to create a recipient bed.
Recession defects were thoroughly scaled using Gracey
curettes (Hu-Friedy Inc., Chicago, IL, USA). No root condi-
tioning was used.
In the test group, just before the surgery, intravenous
blood was collected in 10-mL glass-coated plastic tubes
without anticoagulants and, as recommended by the
manufacturer, immediately centrifuged at 2700 rpm for 12
minutes. After the centrifugation, the fibrin clot was
removed from the tube with sterile tweezers, and the
attached red blood cells were shaved off and discarded
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BOX and compressed by a cover to create a fibrin mem-
brane. The fibrin clots were positioned over the recession
defects, just below the CEJ with sling 5e0 bioabsorbable
sutures. The mucogingival flap was repositioned as coro-
nally as possible and sutured with 4e0 silk sutures (Fig. 1).
In the control group, donor connective tissue was har-
vested from the molarepremolar area of the palate using a
three-sided partial thickness flap to reach the CTG. Alter-
nating incisions were then made on each edge to expand
the “mesh” graft so that it would cover the recipient bed,
which was 1.5 times larger than the graft. Subsequently,
the graft was positioned at the CEJ with sling or interrupted
5e0 bioabsorbable sutures. Then, the mucogingival flap
was repositioned as coronally as possible without tension to
cover the e-MCTG with 4e0 silk sutures (Fig. 2).Postoperative care
Patients were advised to abstain from brushing and flossing
around the surgical area until suture removal (14 days after
surgery) and to consume only soft foods and drinks during
the 1st week after surgery. They were also advised to avoid
any other mechanical trauma to the treated sites. For 4Figure 1 PRF membrane (PRF-M). (A) Preoperative view of rece
fibrin (PRF) clots were transformed into strong PRF-M with PRF BO
bilized by sutures. (E) A full-thickness flap was replaced and suturweeks, all patients rinsed twice a day for 1 minute with a
0.12% chlorhexidine solution, and analgesics were admin-
istered as needed. Two weeks after surgical treatment, all
patients were instructed in mechanical tooth cleaning in
the operated areas using a soft toothbrush. All patients
were examined weekly for the 1st month and once a month
for the next 6 months for oral hygiene motivation.
Statistical analysis
Statistical analysis was performed using a Statistical Pack-
age for Social Sciences software (SPSS Inc., Chicago, IL,
USA). Mean SD were calculated for both test and control
groups for all clinical parameters. One-way analysis of
variance was used to compare pre- and postoperative
clinical measurements within the same group. Student t-
test was used to test the significance of change between
the two treatment groups. The significance level was
determined as 0.05.
Results
Healing was uneventful for all patients, and no patient was
excluded or dropped out of the study. There were nossions. (B) A full-thickness flap was elevated. (C) Platelet-rich
X. (D) PRF-M was placed to cover the exposed roots and sta-
ed. (F) Six months after surgery.
Figure 2 Expanded mesh connective tissue graft (e-MCTG). (A) Preoperative view of recessions. (B) The connective tissue graft
was harvested from palatal mucosa. (C) The expanded mesh connective tissue graft. (D) e-MCTG was placed to cover the exposed
roots and stabilized by sutures. (E) A full-thickness flap was replaced and sutured. (F) Six months after surgery.
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excellent color match and esthetics, was achieved.
Full-mouth PI and GI were maintained at <20%, and the
study teeth were free of biofilm and gingival inflammation
throughout the study.
There were no statistically significant differences be-
tween baseline and postoperative PI and GI scores within
and between groups (P> 0.05). The recession-type defects
were not statistically significant among groups at baseline
(P> 0.05).
At 6 months, both treatments resulted in significant
improvements in the percentage of RC compared with
baseline values. The sites treated with (CAF)þ (PRF-M) had
a mean RC of 95%. For (CAF)þ (e-MTCG), the mean RC was
96.1%. A greater and statistically significant reduction in
recession width was achieved at 6 months with both
treatments (P< 0.05). Both procedures resulted in a sig-
nificant CAL gain at 6 months (P< 0.05).
There were no significant differences in CAL between
the two groups at baseline and 6 months after surgery. We
also observed a decrease in PD in the two groups from
baseline to 6 months. However, the differences within
groups and between groups were not statistically significant
(P> 0.05). Both groups showed a significant increase in KT
from baseline to 6 months (P< 0.05) (Table 2).
In multiple recession defects affecting maxillary teeth,
RD decreased from 4.04 1.22 to 0.2 0.44 and from2.76 1.36 to 0.1 0.17 following (CAF)þ (PRF-M) and
(CAF)þ (e-MCTG) treatment, respectively. Pre- and post-
operative differences within groups were statistically sig-
nificant (PZ 0.02). The difference between the two groups
was not statistically significant. KT increased from
4.2 0.83 to 5.2 0.83 and from 4.26 0.66 to 5.6 0.81
following (CAF)þ (PRF-M) and (CAF)þ (e-MCTG) treatment,
respectively. The mean changes in KT during the study
period were statistically significant between groups
(PZ 0.002). Group (CAF)þ (PRF-M) had a statistically sig-
nificant change in KT (4.2 to 5.2, PZ 0.000) and CAL (5.6 to
1.6, PZ 0.000). Group (CAF)þ (e-MCTG) had a statistically
significant change in KT (4.26 to 5.6, PZ 0.000) and CAL
(4.43 to 1.1, PZ 0.000) (Table 3).
In multiple recession defects affecting mandibular
teeth, RD decreased from 5.09 1.11 to 1.55 2.06 and
3.21 0.87 to 0.10 0.29 following (CAF)þ (PRF-M) and
(CAF)þ (e-MCTG) treatment, respectively. The RD mea-
surements at initial examination and final examination
were statistically significant between groups (PZ 0.000
and PZ 0.026, respectively). However, mean changes in RD
were not statistically significant between groups (P> 0.05).
KT increased following both treatments. Initial and final
examinations of KT were statistically significant within
groups (PZ 0.000). The results of KT obtained in the
(CAF)þ (e-MCTG) group after 6 months of surgery were
superior in a statistically significant manner in relation to
Table 2 Clinical parameters measured at baseline and at 6 months postoperatively.
Clinical
parameters
Baseline
(CAF)þ (PRF-M) group
nZ 54 teeth (mean SD)
Six mo
(CAF)þ (PRF-M) group
nZ 54 teeth (mean SD)
Baseline
(CAF)þ (e-MCTG) group
nZ 52 teeth (mean SD)
Six mo
(CAF)þ (e-MCTG) group
nZ 52 teeth (mean SD)
PD 1.53 0.17 1.31 0.14 1.38 0.58 1.13 0.35
RD 4.73 1.30 1.17 1.47* 3.11 0.80 0.11 0.27*
RW 2.92 0.36 0.96 0.62* 3.07 0.65 0.11 0.27*
KT 3.45 1.05 4.63 0.86* 3.93 0.72 5.11 0.76
CAL 6.27 1.27 2.48 1.41* 4.40 0.86 1.18 0.35*
*Statistically significantly different from baseline within the group (P< 0.05).
(CAF)þ (PRF-M)Z treatment with coronally advanced flap and platelet-rich fibrin membrane; (CAF)þ (e-MCTG)Z treatment with
coronally advanced flap and expanded mesh connective tissue graft; PDZ pocket depth; RDZ recession depth; RWZ recession width;
KTZ keratinized tissue; CALZ clinical attachment level.
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(PZ 0.040). Regarding the initial and final examinations of
CAL, statistically significant differences were observed
within groups (PZ 0.000) (Table 4).
In teeth with RD <4 mm [nZ 16 in the PRF-M group,
nZ 30 in the (CAF)þ (e-MCTG) group], the mean defect
coverage was 59.2% and 93.5% following (CAF)þ (PRF-M)
and (CAF)þ (e-MCTG) treatment, respectively. There was a
statistically significant difference between the groups
(PZ 0.012). A significant reduction in GR length was
noticed at the end of the study for both groups (P< 0.05).
KT increased following both treatments. Results of initial
and final examinations of KT and CAL were statistically
significant within groups (PZ 0.000). Statistically signifi-
cant differences were observed between groups in the
initial and final examinations of CAL parameter (PZ 0.022
and PZ 0.002, respectively) (Table 5).
In teeth with RD 4 mm [nZ 38 in the (CAF)þ (PRF-M)
group, nZ 22 in the e-MCTG group], the mean coverage
was 75% and 100% following (CAF)þ (PRF-M) and (CAF)þ (e-
MCTG) treatment, respectively. A statistically significant
difference was noticed between the groups (PZ 0.030).
Both groups showed statistically significant results in KT and
CAL at 6 months after surgery, compared to the baseline
value (PZ 0.000). The (CAF)þ (e-MCTG) group showed
statistically better results than the (CAF)þ (PRF-M) group
for CAL parameter at baseline (PZ 0.035) (Table 5).Discussion
Several surgical techniques have been described to achieve
a predictable RC of exposed root surfaces. The CTG pro-
cedure is the “gold standard” as far as predictability and
esthetic results are concerned. It was demonstrated that e-
MCTG is also an effective and predictable treatment mo-
dality for the management of MARD in terms of RC, increase
in keratinized tissue, and gain in CAL.
PRF is a second-generation platelet concentrate,21
because it has several advantages over PRP. Using PRF re-
quires a simpler technique and requires less chair-side time
than PRP; it does not require the addition of bovine
thrombin-like PRP.21 Second, the preparation process con-
ceives a gel-like matrix that contains a high concentration
of platelets enmeshed in a fibrin matrix, which releases ahigh concentration of growth factors over a long time.36
Third, it can be squeezed to form a membrane and can
be used as fibrin bandage acting as a matrix to promote the
healing of wound edges.37,38 PRF is considered a healing
biomaterial and is used to enhance bone regeneration and
soft tissue healing in implant and periodontal plastic sur-
gery procedures.
It was demonstrated that the platelets in PRF released
high quantities of three main growth factors (PDGF-AB,
VEGF, and TGFb-1) and an important coagulation matri-
cellular glycoprotein (thrombospondin-1) during 7 days.23
Simon et al39 showed that healing was more rapid in
extraction sites that were treated with the PRF matrix.
Dohan et al evaluated the effect of PRF on human primary
cultures of gingival fibroblasts, dermal prekeratinocytes
and maxillofacial osteoblasts in vitro, and they demon-
strated that PRF induced a significant and continuous
stimulation and proliferation of all these cell types.22,26
Furthermore, PRF induced a strong differentiation in the
osteoblasts.26
Thus, the aim of this split-mouth randomized clinical
study was to evaluate the results of (CAF)þ (PRF-M) for the
treatment of MARD, and also to compare these results with
those obtained with e-MCTG (CAF)þ (e-MCTG).
At baseline, none of the measured clinical variables
showed any statistical difference between the test and
control groups, thus ensuring the same starting point for
both procedures tested.
There were also no statistically significant differences
between the recession-type defects in the two groups at
baseline. Although the silk sutures remained in place for 14
days, as expected there was no plaque accumulation over
the sutures because the patients were advised to use
chlorhexidine solution two times a day. In the present
study, there were no statistically significant differences
between the (CAF)þ (e-MCTG) and (CAF)þ (PRF-M) groups
in terms of gingival recession, gain in CAL at 6 months. This
similar amount of recession reduction indicates that both
surgical techniques are highly effective in achieving RC.
At 6 months, the amount of recession reduction obtained
with PRF-M was similar to that obtained with (CAF)þ (e-
MCTG). The mean percentage of RC was 95% in the test
group and 96.1% in the control group. This result was clin-
ically relevant and statistically significant. Furthermore,
complete RC was achieved in the majority of treated cases:
Table 3 Measurements of RD, KT and CAL in maxilla at seline and 6 months for (CAF)þ (PRF-M) and (CAF)þ (e-MCTG) treated sites.
Maxilla
RD KT CAL
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Me changes
in (in mm)
at seline
an t 6 mo
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Mean changes
in KT (in mm)
at baseline
and at 6 mo
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Mean changes
in CAL (in mm)
at baseline
and at 6 mo
(CAF)þ (PRF-M)
nZ 21
4.04 1.22 0.2 0.44 3.  1.65 4.2 0.83 5.2 0.83 1.0 0.0 5.6 1.16 1.6 0.51 4.0 1.68
(CAF)þ (e-MCTG)
nZ 20
2.76 1.36 0.1 0.17 2.  1.35 4.26 0.66 5.6 0.81 1.33 0.15 4.43 0.51 1.1 0.17 3.33 0.65
P 0.221 0.730 0. 0.911 0.534 0.002* 0.159 0.167 0.545
< 01** <0.001** <0.001**
*Statistically significantly different between groups (P< 0.05
**Statistically significantly different within groups (P< 0.05).
(CAF)þ (PRF-M)Z treatment with coronally advanced flap an latelet-rich fibrin membrane; (CAF)þ (e-MCTG)Z treatment with coronally advanced flap and expanded mesh connective
tissue graft; RDZ recession depth; KTZ keratinized tissue; LZ clinical attachment level.
Table 4 Measurements of RD, KT and CAL in mandibula t baseline and 6 months for (CAF)þ (PRF-M) and (CAF)þ (e-MCTG) treated sites.
Mandibula
RD KT CAL
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Mean hanges
in RD n mm)
at ba line and
at 6
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Mean changes
in KT (in mm)
at baseline and
at 6 mo
Initial
examination
(mean SD)
(mm)
Final
examination
(mean SD)
(mm)
Mean changes
in CAL (in mm)
at baseline and
at 6 mo
(CAF)þ (PRF-M)
nZ 33
5.09 1.11 1.55 2.06 3.54 .09 3.1 0.87 4.3 0.82 1.2 0.63 6.5 1.07 2.84 2.01 3.71 2.2
(CAF)þ
(e MCTG)
nZ 32
3.21 0.87 0.10 0.29 3.10 .97 3.77 0.79 4.97 0.73 1.2 0.38 4.54 1.06 1.27 0.44 3.26 0.95
P <0.001* 0.026* 0.53 0.072 0.040* 0.589 <0.001* 0.016* 0.535
<0.0 ** <0.001** <0.001**
*Statistically significantly different between groups (P< 0.05
**Statistically significantly different within groups (P< 0.05).
(CAF)þ (PRF-M)Z treatment with coronally advanced flap an latelet-rich fibrin membrane; (CAF)þ (e-MCTG)Z treatment with coronally advanced flap and expanded mesh connective
tissue graft; RDZ recession depth; KTZ keratinized tissue; LZ clinical attachment level.
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Treatment of multiple recession-type defects 4312 of the 15 (80%) treated sites in the control group, and 11
of the 15 (73.3%) treated sites in the test group. This result
is similar with those reported in previous studies. There
were no statistically significant differences between the
groups for the percentages of RC and for the prevalence of
complete RC.40
In the test group, the RC for teeth with RD <4 mm was
lower than that in teeth with RD 4 mm at baseline. Thus,
(CAF)þ (PRF-M) for deeper sites seemed to be a highly
predictable procedure, whereas for shallow sites, its
outcome was substantially less predictable.
A greater and statistically significant decrease in the
width of GR was observed in both groups in the present
study (from 2.92 0.36 to 0.96 0.62 for the test group
and from 3.07 0.65 to 0.11 0.27 for the control group).
Moreover, similar amounts of decrease in the width of GR
were found for teeth with RD <4 mm and teeth with RD
4 mm at the end of the study.
Both procedures resulted in a significant CAL gain at 6
months (from 6.27 1.27 to 2.48 1.41 and from
4.40 0.86 to 1.18 0.35 for the test and control groups,
respectively). There were no significant differences in CAL
between the two groups at baseline and 6 months after
surgery.
Studies showed that the increase in the thickness of
gingival tissue is a desired effect in decreasing the possi-
bility of recurrence of GR.40 In the present study, a signif-
icant increase in KT was detected in both groups at
6 months after surgery. This increase is statistically signif-
icant within groups for both maxillary and mandibular sites.
In our study, we observed statistically significant im-
provements in all clinical parameters evaluated in this
research from baseline to the 6th month of examination
with the exception of PD. This was an expected result,
because the patient selection criteria excluded the sites
with PD >2 mm, and the patients have good plaque control
(full-mouth PI <20%).
The present study design did not allow a direct com-
parison between maxillar and mandibular teeth with mul-
tiple recession defects. To our knowledge, the initial
thicknesses of the flap and the type of dissection have a
greater or lesser effect on connective tissue microcircula-
tion. Furthermore, the gingiva on maxilla and mandibula
has different thickness values. The interposition of PRF may
restrict the collateral circulation, which is essential for a
thin flap to revascularize and heal. This variation may be
attributable to the differences in RC between jaws. By
contrast, muscle pull during healing often leads to incom-
plete RC at relapse of the recession. Different percentage
rates of gingival recession coverage may be observed in
maxilla and mandibula because of the differences in the
muscle pull between the two jaws.
Consideration of optimizing both blood supply and es-
thetics dictated a vertically placed vestibular incision. In
the maxillar esthetic zone, this may be lead to changes in
the healing period between the jaws. In our study, a
vertically placed vestibular incision was not used. Accord-
ing to our results, the mean changes in RD were 3.84 1.65
and 3.54 2.09 for recession defects on maxillar and
mandibular teeth, treated with (CAF)þ (PRF-M), respec-
tively. The recession coverage amounts were 2.66 1.35
and 3.10 0.97 for maxillar and mandibular teeth, treated
44 A. Uraz et alwith (CAF)þ (e-MCTG), respectively. No statistically sig-
nificant differences were observed between coverage rate
of maxillar and mandibular recession defects treated with
both (CAF)þ (PRF-M) and (CAF)þ (e-MTCG).
To our knowledge, this is the first study to compare the
effects of (CAF)þ (PRF-M) and (CAF)þ (e-MCTG) to treat
MARD. Therefore, a direct comparison with other studies is
not possible. Aroca et al11 evaluated the combination of
CAF and PRF-M for the treatment of adjacent multiple
gingival recessions and failed to find any additional benefits
of PRF-M combined with CAF in terms of the clinical pa-
rameters used in this study. This can be attributed to the
dehydration of the membrane and the inadequate volume
of the membrane. Quick handling is the only way to obtain
a clinically usable PRF clot.
In the present study, shallow PD and improved CAL
values were observed at the 6th month of evaluation, in
agreement with other studies. Those results are associated
with the attachment of the graft to the root surface
through a combination of epithelial down growth and con-
nective tissue attachment.
In conclusion, the results of this study indicated that
both e-MCTG and PRF-M are effective and predictable
treatment modalities for the management of multiple
recessions-type defects in terms of RC, increase in kerati-
nized tissue, and gain in CAL. Furthermore, PRF-M can be
used successfully in the treatment of multiple recessions.
More expanded studies with larger numbers of patients and
longer evaluation periods are needed to confirm these
results.
Conflicts of interest
The authors have no conflicts of interest relevant to this
article.
Acknowledgments
This research was funded by Gazi University Research Grant
(03/10-12).
References
1. Camargo PM, Melnick PR, Kenney EB. The use of free gingival
grafts for aesthetic purposes. Periodontology 2000 2001;27:
72e96.
2. Wennstrom JL. Mucogingival therapy. Ann Periodontol 1996;1:
671e701.
3. Trott JR, Love B. An analysis of localized gingival recession in
766 Winnipeg High School students. Dent Pract Dent Rec 1966;
16:209e13.
4. Albandar JM, Kingman A. Gingival recession, gingival bleeding,
and dental calculus in adults 30 years of age and older in the
United States, 1988e1994. J Periodontol 1999;70:30e43.
5. Susin C, Haas AN, Oppermann RV, Haugejorden O, Albandar JM.
Gingival recession: epidemiology and risk indicators in a
representative urban Brazilian population. J Periodontol 2004;
75:1377e86.
6. van Palenstein Helderman WH, Lembariti BS, van der
Weijden GA, van’t Hof MA. Gingival recession and its associa-
tion with calculus in subjects deprived of prophylactic dental
care. J Clin Periodontol 1998;25:106e11.7. Al-Wahadni A, Linden GJ. Dentine hypersensitivity in Jordanian
dental attenders. A case control study. J Clin Periodontol
2002;29:688e93.
8. Danesh-Meyer MJ, Wikesjo UM. Gingival recession defects and
guided tissue regeneration: a review. J Periodontal Res 2001;
36:341e54.
9. Roccuzzo M, Bunino M, Needleman I, Sanz M. Periodontal
plastic surgery for treatment of localized gingival recessions: a
systematic review. J Clin Periodontol 2002;29:S178e94.
10. Chambrone L, Sukekava F, Araujo MG, Pustiglioni FE,
Chambrone LA, Lima LA. Root-coverage procedures for the
treatment of localized recession-type defects: a Cochrane
systematic review. J Periodontol. 2010;81:452e78.
11. Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D. Clinical
evaluation of a modified coronally advanced flap alone or in
combination with a platelet-rich fibrin membrane for the
treatment of adjacent multiple gingival recessions: a 6-month
study. J Periodontol 2009;80:244e52.
12. Weng D, Hurzeler MB, Quinones CR, Pechsta¨dt B, Mota L,
Caffesse RG. Healing patterns in recession defects treated with
ePTFE membranes and with free connective tissue grafts. A
histologic and histometric study in the beagle dog. J Clin
Periodontol 1998;25:238e45.
13. Gottlow J, Nyman S, Karring T, Lindhe J. Treatment of local-
ized gingival recessions with coronally displaced flaps and
citric acid. An experimental study in the dog. J Clin Perio-
dontol 1986;13:57e63.
14. Caffesse RG, Kon S, Castelli WA, Nasjleti CE. Revascularization
following the lateral sliding flap procedure. J Periodontol 1984;
55:352e8.
15. Wilderman MN, Wentz FM. Repair of a dentogingival defect
with a pedicle flap. J Periodontol 1965;36:218e31.
16. Miller Jr PD. Root coverage using the free soft tissue autograft
following citric acid application: III. A successful and predict-
able procedure in areas of deep-wide recession. Int J Peri-
odontics Restorative Dent 1985;5:14e37.
17. Abbas F, Wennstrom J, Van der Weijden F, Schneiders T, Van
der Velden U. Surgical treatment of gingival recessions using
emdogain gel: clinical procedure and case reports. Int J Peri-
odontics Restorative Dent 2003;23:607e13.
18. Petrungaro PS. Using platelet-rich plasma to accelerate soft
tissue maturation in esthetic periodontal surgery. Compend
Contin Educ Dent 2001;22:729e32.
19. Kawase T, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasma-
derived fibrin clot formation stimulates collagen synthesis in
periodontal ligament and osteoblastic cells in vitro. J Perio-
dontol 2003;74:858e64.
20. Anitua E. Plasma rich in growth factors: preliminary results of
use in the preparation of future sites for implants. Int J Oral
Maxillofac Implants 1999;14:529e35.
21. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF):
a second-generation platelet concentrate: Part I. Technolog-
ical concepts and evolution. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 2006;101:37e44.
22. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification
of platelet concentrates: from pure platelet-rich plasma (P-
PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends
Biotechnol 2009;27:158e67.
23. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G.
Slow release of growth factors and thrombospondin-1 in
Choukroun’s platelet-rich fibrin (PRF): a gold standard to
achieve for all surgical platelet concentrates technologies.
Growth Factors 2009;27:63e9.
24. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin
(PRF): a second-generation platelet concentrate: Part III.
Leucocyte activation: a new feature for platelet concentrates.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:
51e5.
Treatment of multiple recession-type defects 4525. Huang FM, Yang SF, Zhao JH, Chang YC. Platelet-rich fibrin
increases proliferation and differentiation of human dental
pulp cells. J Endod 2010;36:1628e32.
26. Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP,
Charrier JB. In vitro effects of Choukroun’s PRF (platelet-rich
fibrin) on human gingival fibroblasts, dermal prekeratinocytes,
preadipocytes, and maxillofacial osteoblasts in primary cul-
tures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;
108:341e52.
27. Chang YC, Zhao JH. Effects of platelet-rich fibrin on human
periodontal ligament fibroblasts and application for peri-
odontal infrabony defects. Aust Dent J 2011;56:365e71.
28. Wu CL, Lee SS, Tsai CH, Lu KH, Zhao JH, Chang YC. Platelet-
rich fibrin increases cell attachment, proliferation and
collagen-related protein expression of human osteoblasts. Aust
Dent J 2012;57:207e12.
29. Tsai CH, Shen SY, Zhao JH, Chang YC. Platelet-rich fibrin
modulates cell proliferation of human periodontally related
cells in vitro. J Dent Sci 2009;4:130e5.
30. Dohan Ehrenfest DM. How to optimize the preparation of
leukocyte- and platelet-rich fibrin (L-PRF, Choukroun’s tech-
nique) clots and membranes: introducing the PRF Box. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:275e8.
31. Zhao JH, Tsai CH, Chang YC. Clinical and histologic evaluations
of healing in an extraction socket filled with platelet-rich
fibrin. J Dent Sci 2011;6:116e22.
32. Chang YC, Wu KC, Zhao JH. Clinical application of platelet-rich
fibrin as the sole grafting material in periodontal intrabony
defects. J Dent Sci 2011;6:181e8.33. Zhao JH, Tsai CH, Chang YC. Management of radicular cysts using
platelet-rich fibrin and bioactive glass: a report of two cases. J
Formos Med Assoc. 2012. http://dx.doi.org/10.1016/
j.jfma.2011.09.027.
34. Silness J, Loe H. Periodontal disease in pregnancy: II. Corre-
lation between oral hygiene and periodontal condtion. Acta
Odontol Scand 1964;22:121e35.
35. Loe H, Silness J. Periodontal disease in pregnancy: I. Preva-
lence and severity. Acta Odontol Scand 1963;21:533e51.
36. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF):
a second-generation platelet concentrate: Part II. Platelet-
related biologic features. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod 2006;101:45e50.
37. Gassling VL, Acil Y, Springer IN, Hubert N, Wiltfang J. Platelet-
rich plasma and platelet-rich fibrin in human cell culture. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:48e55.
38. Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous
platelet-rich fibrin in the treatment of intra-bony defects: a
controlled clinical trial. J Clin Periodontol 2011;38:925e32.
39. Simon BI, Zatcoff AL, Kong JJ, O’Connell SM. Clinical and histo-
logical comparison of extraction sockethealing following theuse
of autologous platelet-rich fibrin matrix (PRFM) to ridge pres-
ervationprocedures employingdemineralized freezedriedbone
allograft material and membrane. Open Dent J 2009;3:92e9.
40. Zucchelli G, De Sanctis M. Treatment of multiple recession-
type defects in patients with esthetic demands. J Perio-
dontol 2000;71:1506e14.
